Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Digestive Diseases (CDD) is a world-renowned medical institution specializing in the research and treatment of gastrointestinal disorders, particularly through innovative microbial therapies. Founded by Professor Thomas Borody, the center is a pioneer in Fecal Microbiota Transplantation (FMT) and was instrumental in developing the 'Triple Therapy' cure for Helicobacter pylori. CDD provides specialized clinical services for complex conditions such as Ulcerative Colitis, Crohn's Disease, and Clostridioides difficile infection while actively conducting clinical trials to expand the applications of gut microbiome restoration. The center operates as both a high-level clinical practice and a research hub for gastroenterology and microbiome-based medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Digestive Diseases.